Cytotoxicity and cell cycle changes in prostate cancer cells with differing PSMA expression and p53 status after treatment with PSMA-targeting radioligand [212Pb]Pb-AB001.

AB001 - ARTBIO

FB3001 - Frontier Biotech

http://www.ncbi.nlm.nih.gov/pubmed/41318731

Andrius Kleinauskas; Asta Juzeniene; Rina Wangen-Riise; Rugile Liukaityte; Sandra Kvarsvik Kristiansen; Victoria Dunne; Vilde Yuli Stenberg

Nov 30, 2025